Review: Therapetic Approach in the Management of Osteoarthritis

Authors

  • Snehal H. Gawai Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108
  • Nilakshi N. Dhoble Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108
  • Nitin Padole Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108
  • Pankaj Dhapke Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108
  • Jagdish R. Baheti Baheti Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

DOI:

https://doi.org/10.22270/ajprd.v11i1.1220

Keywords:

Osteoarthritis, Modified drug delivery, Sustained release tablet, Pre-compression and post-compression studies.

Abstract

Objectives: The goal in designing sustained or controlled delivery systems is to reduce the frequency of dosing or to increase the effectiveness of the drug by localization at the site of action, reducing the dose required, and providing uniform drug delivery. A sustained release system is a type of modified drug delivery system that can be used as an alternative to a conventional drug delivery system.

Summary: Osteoarthritis is a generative disease of synovial joints characterized by focal loss of articular hyaline cartilage with the proliferation of new bones and remodelling of joint contour. Risk factors of osteoarthritis are age, female gender, joint alignment, hereditary gene defect, joint injury and obesity.There are various symptoms of osteoarthritis and It diagnose by blood test, joint fluid test and MRI. Osteoarthritis is treated by self-care, medications, therapies, and surgeries. A sustained-release dosage form is a dosage form that maintains the therapeutic blood or tissue levels of the drug by continuous release of medication. Formulation of granules by wet granulation and the granules are evaluated by the pre-compression and post-compression studies.

Conclusion: Sustained release tablet optimize drug release for extended time period.It maximized effectiveness, reduced side-effects of drug and cures the disease.

 

Downloads

Download data is not yet available.

Author Biographies

Snehal H. Gawai, Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Nilakshi N. Dhoble, Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Nitin Padole, Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Pankaj Dhapke, Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Jagdish R. Baheti Baheti, Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

Kamla Nehru College of pharmacy Butibori, Nagpur Maharashtra (India)-441108

References

1. Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SM, Kraus VB, Lohmander LS, Abbott JH, Bhandari M, Blanco FJ. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and cartilage. 2019 Nov 1;27(11):1578-89.
2. Mandl LA. Osteoarthritis year in review 2018: clinical. Osteoarthritis and cartilage. 2019 Mar 1;27(3):359-64.
3. Yin F, Yang Q, He Y, Peng L, Zhao Z, He C, Chen J. Top 100 cited articles on osteoarthritis from 1990 to 2020. Rheumatology and Immunology Research. 2021 Dec 1;2(4):241-8.
4. Shamsi M, Safari A, Soroush A, Safari Y. The survey of knee osteoarthritis in the population over age 50 visited in the health bus in Kermanshah, Iran. Journal of aging research. 2021 Nov 12;2021.
5. Gürer G, Bozbas GT, Tuncer T, Unubol AI, Ucar UG, Memetoglu OI. Frequency of joint hypermobility in Turkish patients with knee osteoarthritis: a cross sectional multicenter study. International Journal of Rheumatic Diseases. 2018 Oct;21(10):1787-92.
6. Turkiewicz A, Gerhardsson de Verdier M, Engström G, Nilsson PM, Mellström C, Lohmander LS, Englund M. Prevalence of knee pain and knee OA in southern Sweden and the proportion that seeks medical care. Rheumatology. 2015 May 1;54(5):827-35.
7. Vignon E, Valat JP, Rossignol M, Avouac B, Rozenberg S, Thoumie P, Avouac J, Nordin M, Hilliquin P. Osteoarthritis of the knee and hip and activity: a systematic international review and synthesis (OASIS). Joint Bone Spine. 2006 Jul 1;73(4):442-55.
8. Li Y, Wei X, Zhou J, Wei L. The age-related changes in cartilage and osteoarthritis. BioMed research international. 2013 Jan 1;2013.
9. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best practice & research Clinical rheumatology. 2006 Feb 1;20(1):3-25.
10. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clinics in geriatric medicine. 2010 Aug 1;26(3):355-69.
11. Goldring MB, Otero M. Inflammation in osteoarthritis. Current opinion in rheumatology. 2011 Sep;23(5):471.
12. Kloppenburg M, Berenbaum F. Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthritis and cartilage. 2020 Mar 1;28(3):242-8.
13. Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019 Sep 1;37(Suppl 120):3-6.
14. Franklin SP, Park RD, Egger EL. Metacarpophalangeal and metatarsophalangeal osteoarthritis in 49 dogs. Journal of the American Animal Hospital Association. 2009;45(3):112-7.
15. Collins NJ, Hart HF, Mills KA. Osteoarthritis year in review 2018: rehabilitation and outcomes. Osteoarthritis and cartilage. 2019 Mar 1;27(3):378-91.
16. Elders MJ. The increasing impact of arthritis on public health. The Journal of Rheumatology. Supplement. 2000 Oct 1;60:6-8.
17. Herbolsheimer F, Ungar N, Portegijs E, Dallmeier D, Schaap L, Smith T, Stubbs B, Deeg D, Peter R, Castell MV, Otero Á. Neighborhood environment, social participation, and physical activity in older adults with lower limb osteoarthritis: A mediation analysis. Health & Place. 2021 Mar 1;68:102513.
18. De Filippis L, Gulli S, Caliri A, Romano C, Munaò F, Trimarchi G, La Torre D, Fichera C, Pappalardo A, Triolo G, Gallo M. Epidemiology and risk factors in osteoarthritis: literature review data from “OASIS” study. Reumatismo. 2004;56(3):169-84.
19. Zeng QY, Zang CH, Li XF, Dong HY, Zhang AL, Lin L. Associated risk factors of knee osteoarthritis: a population survey in Taiyuan, China. Chinese medical journal. 2006 Sep 20;119(18):1522-7.
20. Field T. Knee osteoarthritis pain in the elderly can be reduced by massage therapy, yoga and tai chi: a review. Complementary therapies in clinical practice. 2016 Feb 1;22:87-92.
21. Krishnan V, Pithadia K. Effect of retro walking versus balance training on pain and disability in patients with osteoarthritis of the knee: a randomized controlled trial. Bulletin of Faculty of Physical Therapy. 2021 Dec;26(1):1-7.
22. Ray A, Ray BK. An inflammation-responsive transcription factor in the pathophysiology of osteoarthritis. Biorheology. 2008 Jan 1;45(3-4):399-409.
23. Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM. A systematic review of recommendations and guidelines for the management of osteoarthritis: the chronic osteoarthritis management initiative of the US bone and joint initiative. InSeminars in arthritis and rheumatism 2014 Jun 1 (Vol. 43, No. 6, pp. 701-712). WB Saunders.
24. Pappa E, Papadopoulos S, Korou LM, Perrea DN, Pneumaticos S, Nikolaou VS. The role of intra-articular administration of Fetuin-A in post-traumatic knee osteoarthritis: an experimental study in a rat model. Journal of experimental orthopaedics. 2019 Dec;6(1):1-10.
25. Hinton R, David AK, Thomas SF, Moody RL. Osteoarthritis: diagnosis and therapeutic considerations. American family physician. 2002 Mar 1;65(5):841.
26. Tanrisever M. Current treatment methods in osteoarthritis. Clinical and basic studies in veterinary medicine. 2021 Jan, pp.21-47
27. Soliman DM, Sherif NM, Omar OH, El Zohiery AK. Healing effects of prolotherapy in treatment of knee osteoarthritis healing effects of prolotherapy in treatment of knee osteoarthritis. Egyptian Rheumatology and Rehabilitation. 2016 Apr;43(2):47-52.
28. Hua Z, Deng H, Tang H, Ruan Z, Wang P, Zhang M, Ma H, Wang P, Dong C, Huang Z, Hong H. Clinical Study of Acupotomy for Knee Osteoarthritis Based on the Meridian-Sinew Theory: A Randomized Controlled Clinical Trial. Evidence-Based Complementary and Alternative Medicine. 2021 Nov 18;2021.pp.1-9
29. Lund H, Weile U, Christensen R, Rostock B, Downey A, Bartels EM, Danneskiold-Samsøe B, Bliddal H. A randomized controlled trial of aquatic and land-based exercise in patients with knee osteoarthritis. Journal of rehabilitation medicine. 2008 Feb 5;40(2):137-44.
30. Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis research & therapy. 2013 Jul;15(3):1-10.
31. Seedher N, Bhatia S. Solubility enhancement of Cox-2 inhibitors using various solvent systems. Aaps Pharmscitech. 2003 Sep;4(3):36-44.
32. Lascelles BD, Gaynor JS, Smith ES, Roe SC, Marcellin‐Little DJ, Davidson G, Boland E, Carr J. Amantadine in a multimodal analgesic regimen for alleviation of refractory osteoarthritis pain in dogs. Journal of Veterinary Internal Medicine. 2008 Jan;22(1):53-9.
33. Rychel, J.K. Diagnosis and treatment of osteoarthritis. Topics in Companion Animal Medicine. 2010;25(1):20-25.
34. Taruc-Uy, R.L. and Lynch, S.A. Diagnosis and treatment of osteoarthritis. Primary Care: Clinics in Office Practice. 2013;40(4):821-836.
35. Panainte AD, Gafitanu C, Stoleriu I, Tarțău LM, Popescu MC, Lisa G, Popa EG. New modified release tablets of bisoprolol fumarate for the treatment of hypertension: characterization and in vitro evaluation. Journal of Drug Delivery Science and Technology. 2019 Apr 1;50:402-9.
36. Dixit, N., Maurya, S.D. and Sagar, B.P. Sustained release drug delivery system. Indian Journal of Research in Pharmacy and Biotechnology. 2013;1(3):305.
37. Ratnaparkhi, M.P. and Gupta Jyoti, P. Sustained release oral drug delivery system-an overview. Terminology. 2013;3(4):10-22.
38. Gupta MM, Brijesh R. A review on: sustained release technology. International Journal of Therapeutic Applications. 2012;8:1-23.
39. Venkat Thota. Sustained release oral drug delivery system-an overview. International Journal of Pharma Research. 2015; 2(3):11-21.
40. Park K. Controlled drug delivery systems: past forward and future back. Journal of Controlled Release. 2014 Sep 28;190:3-8.
41. Lasic DD, Barenholz Y. Liposomes: past, present, and future. InHandbook of Nonmedical Applications of Liposomes: From Gene Delivery and Diagnostics to Ecology 2019 Jul 18 (pp. 299-316). CRC Press.
42. Feher VA, Cavanagh J. Millisecond-timescale motions contribute to the function of the bacterial response regulator protein Spo0F. Nature. 1999 Jul;400(6741):289-93.
43. Agarwal RK, Jain H. K. and Singhai, AK, Estimation of Losartan potassium from tablets. Indian Drugs. 2000;37(5):26-30.
44. Davies WL, Gloor Jr WT. Batch production of pharmaceutical granulations in a fluidized bed I: effects of process variables on physical properties of final granulation. Journal of Pharmaceutical Sciences. 1971 Dec 1;60(12):1869-74.
45. Kausar S, Erum A, Tulain UR, Hussain MA, Farid-ul-Haq M, Malik NS, Rashid A. Formulation, In Vitro Evaluation, and Toxicity Studies of A. vulgaris-co-AAm Carrier for Vildagliptin. Advances in Polymer Technology. 2021 Jul 23;2021.
46. Rathore SB, Sharma A, Garg A, Sisodiya DS. Formulation and evaluation of enteric coated tablet of Ilaprazole. International current pharmaceutical journal. 2013 Jun 1;2(7):126-30.
47. Pharmacopoeia I. Government of India, Ministry of Health & Family Welfare, Controller of Publication, New Delhi, India, Vol. 1-2. Received 14th September 2014 Revised 21st September 2014 Accepted 26th September 2014 J. App. Pharm. Res., XI (4). 2007;2014:17-23.
48. Banker GS, Siepmann J, Rhodes C, editors. Modern pharmaceutics. CRC Press; 2002 May 24.fourth edition pp.258
49. Ulla SN, Roy AK, SM VK. Formulation and evaluation of sustained release matrix tablets of lornoxicam. International journal of drug development and research. 2011;3(1):31-44.
50. Karajgi SR, Metri S, Tiwari V, Hulyalkar S, Rub TA, Patil AS. UV spectrophotometric method for the quantitative estimation of celecoxib in capsule dosage forms. Der Pharmacia Lettre. 2016;8(10):247-57.
51. Kannan S, Manivannan R, Ganesan K, Nishad PK, Kumar NS. Formulation and evaluation of sustained release tablets of aceclofenac using hydrophilic matrix system. Int J PharmTech Res. 2010;2(3):1775-80.
52. Venkatesh, D.N., Meyyanathan, S.N., Shanmugam, R., Zielinska, A., Campos, J.R., Ferreira, J.D. and Souto, E.B. Development, in vitro release and in vivo bioavailability of sustained release nateglinide tablets. Journal of Drug Delivery Science and Technology. 2020;55:101355.
53. Vivekananda Rao SR. Formulation and In-Vitro Evaluation of Metronidazole Mucoadhesive Microspheres (Doctoral dissertation, Adhiparasakthi College of Pharmacy, Melmaruvathur).pp.358
54. Kannan S, Manivannan R, Ganesan K, Nishad PK, Kumar NS. Formulation and evaluation of sustained release tablets of aceclofenac using hydrophilic matrix system. Int J PharmTech Res. 2010;2(3):1775-80.
55. Tataratil AS, Kouz J. Investigation into the mechanism of release and formulation, development of sustained release matrix tablets of an antiallergenic, sch-x. Int J Pharm Sci. 2007;4:234-7.
56. Mali RR, Goel V, Gupta S. Novel study in sustained release drug delivery system: A Review. Int. J. Pharm. Med. Res. 2015 Apr 10;3(2):204-15.
57. Yadav IK, Singh HP, Singh RP, Tiwari PK, Chandra D, Jaiswal D, Jain DA. Formulation, evaluation and optimization of aceclofenac sustained release matrix tablets. of International Journal PharmTech Research. 2010;2(1):592-98.
58. Kannan S, Manivannan R, Ganesan K, Nishad PK, Kumar NS. Formulation and evaluation of sustained release tablets of aceclofenac using hydrophilic matrix system. Int J PharmTech Res. 2010;2(3):1775-80.
59. Reddy, M.R. and Kumar, P.K. Formulation and Evaluation of Sustained Release Tablets of Esomeprazole Using Natural and Synthetic Polymers.2021;1-9
60. Savaşer A, Özkan Y, Işımer A. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. Il Farmaco. 2005 Feb 1;60(2):171-7.
61. Démuth B, Nagy ZK, Balogh A, Vigh T, Marosi G, Verreck G, Van Assche I, Brewster ME. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. International journal of pharmaceutics. 2015 May 30;486(1-2):268-86.

Published

2023-02-15

How to Cite

Gawai, S. H., Dhoble, N. N., Padole, N., Dhapke, P., & Baheti, J. R. B. (2023). Review: Therapetic Approach in the Management of Osteoarthritis. Asian Journal of Pharmaceutical Research and Development, 11(1), 52–59. https://doi.org/10.22270/ajprd.v11i1.1220